PD-1 regulates KLRG1+ group 2 innate lymphoid cells

被引:172
作者
Taylor, Samuel [1 ]
Huang, Yuefeng [2 ]
Mallett, Grace [4 ]
Stathopoulou, Chaido [4 ]
Felizardo, Tania C. [1 ]
Sun, Ming-An [3 ]
Martin, Evelyn L. [4 ]
Zhu, Nathaniel [1 ]
Woodward, Emma L. [4 ]
Elias, Martina S. [4 ]
Scott, Jonathan [4 ]
Reynolds, Nick J. [4 ,5 ]
Paul, William E.
Fowler, Daniel H. [1 ]
Amarnath, Shoba [4 ]
机构
[1] NCI, Expt Transplantat Immunol Branch, NIH, Bethesda, MD 20892 USA
[2] NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA
[3] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA
[4] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[5] Royal Victoria Infirm, Dept Dermatol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
基金
美国国家卫生研究院; 英国工程与自然科学研究理事会;
关键词
GASTRIC EPITHELIAL-CELLS; CHRONIC VIRAL-INFECTION; NATURAL HELPER-CELLS; T-CELLS; TYPE-2; IMMUNITY; AIRWAY HYPERREACTIVITY; ALLERGIC INFLAMMATION; LUNG INFLAMMATION; EXPRESSION; MICE;
D O I
10.1084/jem.20161653
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Group 2 innate lymphoid cells (ILC-2s) regulate immune responses to pathogens and maintain tissue homeostasis in response to cytokines. Positive regulation of ILC-2s through ICOS has been recently elucidated. We demonstrate here that PD-1 is an important negative regulator of KLRG1(+) ILC-2 function in both mice and humans. Increase in KLRG1(+) ILC-2 cell numbers was attributed to an intrinsic defect in PD-1 signaling, which resulted in enhanced STAT5 activation. During Nippostrongylus brasiliensis infection, a significant expansion of KLRG1(+) ILC-2 subsets occurred in Pdcd1(-/-) mice and, upon adoptive transfer, Pdcd1(-/-) KLRG1(+) ILC-2s significantly reduced worm burden. Furthermore, blocking PD-1 with an antibody increased KLRG1(+) ILC-2 cell number and reduced disease burden. Therefore, PD-1 is required for maintaining the number, and hence function, of KLRG1(+) ILC-2s.
引用
收藏
页码:1663 / 1678
页数:16
相关论文
共 62 条
[51]   Schistosoma mansoni worms induce anergy of T cells via selective up-regulation of programmed death ligand 1 on macrophages [J].
Smith, P ;
Walsh, CM ;
Mangan, NE ;
Fallon, RE ;
Sayers, JR ;
McKenzie, ANJ ;
Fallon, PG .
JOURNAL OF IMMUNOLOGY, 2004, 173 (02) :1240-1248
[52]   Innate Lymphoid Cells: Emerging Insights in Development, Lineage Relationships, and Function [J].
Spits, Hergen ;
Cupedo, Tom .
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30, 2012, 30 :647-675
[53]   Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles [J].
Subramanian, A ;
Tamayo, P ;
Mootha, VK ;
Mukherjee, S ;
Ebert, BL ;
Gillette, MA ;
Paulovich, A ;
Pomeroy, SL ;
Golub, TR ;
Lander, ES ;
Mesirov, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (43) :15545-15550
[54]   Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis [J].
Terrazas, LI ;
Montero, D ;
Terrazas, CA ;
Reyes, JL ;
Rodríguez-Sosa, M .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2005, 35 (13) :1349-1358
[55]   Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer [J].
Topalian, Suzanne L. ;
Hodi, F. Stephen ;
Brahmer, Julie R. ;
Gettinger, Scott N. ;
Smith, David C. ;
McDermott, David F. ;
Powderly, John D. ;
Carvajal, Richard D. ;
Sosman, Jeffrey A. ;
Atkins, Michael B. ;
Leming, Philip D. ;
Spigel, David R. ;
Antonia, Scott J. ;
Horn, Leora ;
Drake, Charles G. ;
Pardoll, Drew M. ;
Chen, Lieping ;
Sharfman, William H. ;
Anders, Robert A. ;
Taube, Janis M. ;
McMiller, Tracee L. ;
Xu, Haiying ;
Korman, Alan J. ;
Jure-Kunkel, Maria ;
Agrawal, Shruti ;
McDonald, Daniel ;
Kollia, Georgia D. ;
Gupta, Ashok ;
Wigginton, Jon M. ;
Sznol, Mario .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) :2443-2454
[56]   Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction [J].
Trautmann, Lydie ;
Janbazian, Loury ;
Chomont, Nicolas ;
Said, Elias A. ;
Gimmig, Sylvain ;
Bessette, Benoit ;
Boulassel, Mohamed-Rachid ;
Delwart, Eric ;
Sepulveda, Homero ;
Balderas, Robert S. ;
Routy, Jean-Pierre ;
Haddad, Elias K. ;
Sekaly, Rafick-Pierre .
NATURE MEDICINE, 2006, 12 (10) :1198-1202
[57]   Immunobiology of Cancer Therapies Targeting CD137 and B7-H1/PD-1 Cosignal Pathways [J].
Wang, Shengdian ;
Chen, Lieping .
CANCER IMMUNOLOGY AND IMMUNOTHERAPY, 2011, 344 :245-267
[58]   Stat5-deficient hematopoiesis is permissive for Myc-induced B-cell leukemogenesis [J].
Wang, Zhengqi ;
Medrzycki, Magdalena ;
Bunting, Silvia T. ;
Bunting, Kevin D. .
ONCOTARGET, 2015, 6 (30) :28961-28972
[59]   Molecular signature of CD8+ T cell exhaustion during chronic viral infection [J].
Wherry, E. John ;
Ha, Sang-Jun ;
Kaech, Susan M. ;
Haining, W. Nicholas ;
Sarkar, Surojit ;
Kalia, Vandana ;
Subramaniam, Shruti ;
Blattman, Joseph N. ;
Barber, Daniel L. ;
Ahmed, Rafi .
IMMUNITY, 2007, 27 (04) :670-684
[60]   Nivolumab for squamous-cell non-small-cell lung cancer [J].
Yaqub, Farhat .
LANCET ONCOLOGY, 2015, 16 (07) :E319-E319